Verma et al [22] first described the use of the “cancer ratio” (CR), that is, the serum lactate dehydrogenase (LDH) to pleural adenosine deaminase ratio, to identify MPE and reported a high specificity and sensitivity using a cutoff level >20. The gene discussed is ADA; the disease is cancer.